MedTrace Logo

Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

NCT07192991 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-25

No results posted yet for this study

Summary

This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, Mexico, Argentina, and Peru). The research will collect data from medical records to analyze factors like patient demographics, diagnosis methods, tumor characteristics, treatment approaches, and disease progression. The study is non-interventional, meaning patient care will follow standard clinical practice, with data gathered via an electronic system.

Conditions

  • Neuroendocrine Carcinomas
  • Lung Neuroendocrine Carcinoma

Interventions

OTHER

Observational study

This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.

Sponsors & Collaborators

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Grupo Argentino de Investigación Clínica en Oncología

    collaborator UNKNOWN

  • Grupo de Estudios Clínicos Oncológicos Peruano

    collaborator OTHER

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Rachel Simões Pimenta Riechelmann · Latin American Cooperative Oncology Group

  • Vladmir Cláudio Cordeiro de Lima · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2026-06-01
Completion
2026-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07192991 on ClinicalTrials.gov